Verizon's Q1 2025: Unpacking Contradictions on Tariffs, FWA Growth, and Broadband Performance

None



Financial Performance and Revenue Growth:
- Verizon reported strong financial growth in the first quarter of 2025, with wireless service revenue up 2.7%, reaching the high end of their guided range.
- Adjusted EBITDA was $12.6 billion, growing 4%, marking the highest reported result and exceeding their guided range.
- This growth was driven by pricing actions, fixed wireless access subscriber growth, and continued adoption of premium plans.

Segment Performance and Customer Transformation:
- Verizon saw positive improvement in combined postpaid and prepaid phone net adds, with prepaid net adds reaching 137,000, the highest since the TracFone acquisition.
- Broadband contributed significantly with 339,000 net adds, as the company took market share due to its comprehensive offerings and strategic moves.
- The company's consumer transformation efforts, including product enhancements like myPlan, myHome, and AI Connect, resonated with customers, leading to improved customer retention and expansion.

Network Expansion and 5G Deployment:
- Verizon is on track to deploy C-Band to 80% to 90% of its planned sites by year-end, enhancing mobile services and broadening fixed wireless access capabilities.
- Network advancements have led to lower churn rates and increased step-ups in customer plans, contributing positively to financial growth.
- The expansion of 5G advanced features and fixed wireless access solutions is expected to continue driving growth and customer satisfaction.

Consumer Strategy and Marketing Initiatives:
- The launch of the Verizon Value Guarantee, offering a three-year price lock and free phone guarantee, is expected to drive higher gross adds and improve customer retention.
- This strategic move aims to provide predictability and value, aligning with consumer preferences for control and simplicity.
- The integration of value-added services, perks, and premium plans has led to an increase in perks subscriptions, contributing to the company's financial growth.